Cover Image
Market Research Report

Viscosupplementation: Global Market Overview

Published by BCC Research Product code 925590
Published Content info 108 Pages
Delivery time: 1-2 business days
Price
Back to Top
Viscosupplementation: Global Market Overview
Published: February 10, 2020 Content info: 108 Pages
Description

Report Highlights:

The global viscosupplementation market should grow from $3.2 billion in 2018 to $5.9 billion by 2025 at compound annual growth rates (CAGR) of 9.0% for the period of 2018-2025.

Three-Injection cycle viscosupplementation market should grow from $1.6 billion in 2018 to $2.5 billion by 2025 at a CAGR of 6.9% for the period of 2018-2025.

Single-Injection cycle viscosupplementation market should grow from $1.0 billion in 2018 to $2.5 billion by 2025 at a CAGR of 13.6% for the period of 2018-2025.

Report Scope:

The current report offers a detailed picture of the viscosupplementation market. Viscosupplementation is indicated for the treatment of knee, hip, shoulder and ankle osteoarthritis. Hyaluronic acid viscosupplement is injected into joints to reduce joint pains and treat osteoarthritis.

This report highlights the current and future market potential for viscosupplementation and provides a detailed analysis of the competitive environment, regulatory scenario, patent analysis, pipeline analysis, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2025, as well as market shares for key market players.

This report details market shares for viscosupplementation based on procedure type, application and geography. Based on procedure type, the market is segmented into Three-Injection cycle, Single-Injection cycle and Five-Injection cycle procedure segments. Based on application, the market is segmented into knee osteoarthritis, hip osteoarthritis and the others segment.

By geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. Detailed analyses of major countries (the U.S., Canada, Germany, the UK, France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for the year 2018 as the base year, with forecasts for 2019 Through 2025. Estimated values are based on viscosupplement manufacturers total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Report Includes:

  • 39 tables
  • An overview of global viscosupplementation market
  • Detailed market share of viscosupplementation based on product type, procedure type, injection cycle, and application
  • Highlights of current and future market potential of viscosupplementation and a detailed analysis of the competitive environment, regulatory scenario, patent analysis, and drivers, challenges, and trends in market growth
  • Knowledge about hyaluronic acid, a lubricating agent and discussion on how it enables smooth movement of bones
  • Coverage of minimally invasive viscosupplementation procedures, new product innovations, and rapid product advancements
  • Insights into strategic initiatives by major companies including partnerships, agreements, geographic expansions, R&D of products, new product launches, mergers and acquisitions and opportunities for the companies
  • Company profiles of major global corporations within this market, including Anika Therapeutics Inc., Bioventus, Chugai Pharmaceuticals Co., Ltd., Sanofi and Seikagaku Corp.
Table of Contents
Product Code: HLC257A

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Market and Technology Background

  • Osteoarthritis
    • Etiology
    • Epidemiology and Market Burden
    • Prevalence of Osteoarthritis
    • Disease Symptoms
    • Risk Factors
    • Diagnosis
    • Treatments
    • Reducing the Risk of Osteoarthritis

Chapter 4: Market Dynamics

  • Market Drivers
    • Increasing Prevalence of Knee Osteoarthritis
    • Growing Elderly Population
    • Emerging Countries
    • Minimally Invasive Procedures
  • Market Restraints
    • Substitute Treatment Options
    • Intellectual Property
    • Insurance Denials
    • Government Regulations
  • Market Opportunities
    • Patient Preference
    • Strategic Initiatives
    • New Product Launches and R&D

Chapter 5: Market Breakdown by Procedure Type

  • Global Market for Viscosupplementation by Procedure Type
  • Three-Injection Cycle
    • Market Size and Forecast
  • Single-Injection Cycle
    • Market Size and Forecast
  • Five-Injection Cycle
    • Market Size and Forecast

Chapter 6: Market Breakdown by Application

  • Global Market for Viscosupplementation by Application
  • Knee Osteoarthritis
    • Market Size and Forecast
  • Hip Osteoarthritis
    • Market Size and Forecast
  • Other Applications (Shoulder and Ankle Osteoarthritis)
    • Market Size and Forecast

Chapter 7: Market Breakdown by Region

  • Global Market for Viscosupplementation by Region
  • North America
    • United States
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Western Europe
    • Eastern Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Market Size and Forecast
    • Market Analysis
  • Middle East and Africa
    • Market Size and Forecast
    • Market Analysis

Chapter 8: Regulatory Structure: Medical Devices

  • Regulatory Background
  • Regulation of Medical Devices by Country/Region
    • U.S.
    • European Union (EU)
    • Japan

Chapter 9: Competitive Landscape

  • Global Company Market Share Analysis
  • Mergers and Acquisitions
  • Agreements, Contracts, Collaborations and Partnerships
  • New Product Launches

Chapter 10: Company Profiles

  • Major Viscosupplement Manufacturers
    • ANIKA THERAPEUTICS INC.
    • BIOVENTUS
    • CHUGAI PHARMACEUTICAL CO., LTD.
    • FERRING B.V.
    • FIDIA FARMACEUTICI S.P.A.
    • SANOFI
    • SEIKAGAKU CORP.
  • Other Prominent Companies

Chapter 11: Appendix: Acronyms

List of Tables

  • Summary Table A: Global Market for Viscosupplementation, by Procedure Type, Through 2025
  • Summary Table B: Global Market for Viscosupplementation, by Application, Through 2025
    • Table 1: Global Prevalence of Osteoarthritis (Symptomatic), by Region/Country, Through 2018
    • Table 2: Prevalence of Obesity in Males and Females in Australia, 1995-2015
    • Table 3: Global Market for Viscosupplementation, by Procedure Type, Through 2025
    • Table 4: Global Market for Three-Injection Cycle Viscosupplementation, by Region, Through 2025
    • Table 5: Global Market for Single-Injection Cycle Viscosupplementation, by Region, Through 2025
    • Table 6: Global Market for Five-Injection Cycle Viscosupplementation, by Region, Through 2025
    • Table 7: Global Market for Viscosupplementation, by Application, Through 2025
    • Table 8: Global Market for Knee Osteoarthritis Viscosupplementation, by Region, Through 2025
    • Table 9: Global Market for Hip Osteoarthritis Viscosupplementation, by Region, Through 2025
    • Table 10: Global Market for Other Applications in Viscosupplementation, by Region, Through 2025
    • Table 11: Global Market for Viscosupplementation, by Region, Through 2025
    • Table 12: North American Market for Viscosupplementation, by Procedure Type, Through 2025
    • Table 13: North American Market for Viscosupplementation, by Country, Through 2025
    • Table 14: European Market for Viscosupplementation, by Sub-Region, Through 2025
    • Table 15: European Market for Viscosupplementation, by Procedure Type, Through 2025
    • Table 16: Western European Market for Viscosupplementation, by Country, Through 2025
    • Table 17: Asia-Pacific Market for Viscosupplementation, by Procedure Type, Through 2025
    • Table 18: Asia-Pacific Market for Viscosupplementation, by Country, Through 2025
    • Table 19: Latin American Market for Viscosupplementation, by Procedure Type, Through 2025
    • Table 20: Middle Eastern and African Market for Viscosupplementation, by Procedure Type, Through 2025
    • Table 21: Regulatory Approval: U.S. versus Europe
    • Table 22: Global Market Analysis of Viscosupplements, by Company, 2018
    • Table 23: Recent Product Launches: Viscosupplementation Market, 2016-2019
    • Table 24: Recent Product Approvals in the Viscosupplementation Market, 2015-2020
    • Table 25: Anika Therapeutics Inc.: Revenue, 2016-2018
    • Table 26: Anika Therapeutics Inc.: Viscosupplement Products, 2018
    • Table 27: Bioventus: Viscosupplement Products, 2018
    • Table 28: Chugai Pharmaceutical Co., Ltd.: Revenue, 2016-2018
    • Table 29: Chugai Pharmaceutical Co., Ltd.: Viscosupplement Products, 2018
    • Table 30: Ferring B.V.: Revenue, 2016-2018
    • Table 31: Ferring B.V.: Viscosupplement Products, 2018
    • Table 32: Fidia Farmaceutici S.p.A.: Viscosupplement Products, 2018
    • Table 33: Sanofi: Revenue, 2016-2018
    • Table 34: Sanofi: Viscosupplement Products, 2018
    • Table 35: Seikagaku Corp.: Revenue, 2016-2018
    • Table 36: Seikagaku Corp.: Viscosupplement Products, 2018
    • Table 37: Other Prominent Companies in the Viscosupplementation Market
    • Table 38: Acronyms Used in This Report

List of Figures

  • Summary Figure A: Global Market Shares for Viscosupplementation, by Procedure Type, 2018
  • Summary Figure B: Global Market Shares for Viscosupplementation, by Application, 2018
    • Figure 1: Prevalence of Adult Obesity in Selected Countries, 2016
    • Figure 2: Global Market Shares for Viscosupplementation, by Procedure Type, 2018
    • Figure 3: Global Market for Three-Injection Cycle Viscosupplementation, 2017-2025
    • Figure 4: Global Market for Three-Injection Cycle Viscosupplementation, by Region, 2017-2025
    • Figure 5: Global Market for Single-Injection Cycle Viscosupplementation, 2017-2025
    • Figure 6: Global Market for Single-Injection Cycle Viscosupplementation, by Region, 2017-2025
    • Figure 7: Global Market for Five-Injection Cycle Viscosupplementation, 2017-2025
    • Figure 8: Global Market for Five-Injection Cycle Viscosupplementation, by Region, 2017-2025
    • Figure 9: Global Market Shares for Viscosupplementation, by Application, 2018
    • Figure 10: Global Market for Knee Osteoarthritis Viscosupplementation, 2017-2025
    • Figure 11: Global Market for Knee Osteoarthritis Viscosupplementation, by Region, 2017-2025
    • Figure 12: Global Market for Hip Osteoarthritis Viscosupplementation, 2017-2025
    • Figure 13: Global Market for Hip Osteoarthritis Viscosupplementation, by Region, 2017-2025
    • Figure 14: Global Market for Other Applications in Viscosupplementation, 2017-2025
    • Figure 15: Global Market for Other Applications in Viscosupplementation, by Region, 2017-2025
    • Figure 16: Global Market Shares for Viscosupplementation, by Region, 2018
    • Figure 17: North American Market Shares for Viscosupplementation, by Procedure Type, 2018
    • Figure 18: North American Market Shares for Viscosupplementation, by Country, 2018
    • Figure 19: U.S. Market for Viscosupplementation, 2017-2025
    • Figure 20: Canadian Market for Viscosupplementation, 2017-2025
    • Figure 21: European Market Shares for Viscosupplementation, by Region, 2018
    • Figure 22: European Market Shares for Viscosupplementation, by Procedure Type, 2018
    • Figure 23: Western European Market Shares for Viscosupplementation, by Country, 2018
    • Figure 24: UK Market for Viscosupplementation, 2017-2025
    • Figure 25: German Market for Viscosupplementation, 2017-2025
    • Figure 26: French Market for Viscosupplementation, 2017-2025
    • Figure 27: Italian Market for Viscosupplementation, 2017-2025
    • Figure 28: Spanish Market for Viscosupplementation, 2017-2025
    • Figure 29: Rest of Western European Market for Viscosupplementation, 2017-2025
    • Figure 30: Eastern European Market for Viscosupplementation, 2017-2025
    • Figure 31: Asia-Pacific Market Shares for Viscosupplementation, by Procedure Type, 2018
    • Figure 32: Asia-Pacific Market Shares for Viscosupplementation, by Country, 2018
    • Figure 33: Japanese Market for Viscosupplementation, 2017-2025
    • Figure 34: Chinese Market for Viscosupplementation, 2017-2025
    • Figure 35: Indian Market for Viscosupplementation, 2017-2025
    • Figure 36: Australian Market for Viscosupplementation, 2017-2025
    • Figure 37: South Korean Market for Viscosupplementation, 2017-2025
    • Figure 38: Rest of Asia-Pacific Market for Viscosupplementation, 2017-2025
    • Figure 39: Latin American Market for Viscosupplementation, 2017-2025
    • Figure 40: Latin American Market Shares for Viscosupplementation, by Procedure Type, 2018
    • Figure 41: Middle Eastern and African Market for Viscosupplementation, 2017-2025
    • Figure 42: Middle Eastern and African Market Shares for Viscosupplementation, by Procedure Type, 2018
    • Figure 43: Global Market Shares for Viscosupplementation, by Major Manufacturer, 2018
    • Figure 44: Anika Therapeutics Inc.: Revenue Share, by Region, 2018
    • Figure 45: Anika Therapeutics Inc.: Revenue Share, by Business Segment, 2018
    • Figure 46: Anika Therapeutics Inc.: Orthobiologics Segment Sales Revenue, 2015-2018
    • Figure 47: Anika Therapeutics Inc.: R&D Expenditures, 2015-2018
    • Figure 48: Chugai Pharmaceutical Co., Ltd.: Revenue Share, by Region, 2018
    • Figure 49: Chugai Pharmaceutical Co., Ltd.: Revenue Share, by Business Segment, 2018
    • Figure 50: Chugai Pharmaceutical Co., Ltd.: Sales Revenue from Suvenyl, 2015-2018
    • Figure 51: Chugai Pharmaceutical Co., Ltd.: R&D Expenditures, 2015-2018
    • Figure 52: Ferring B.V.: Revenue Share, by Region, 2018
    • Figure 53: Ferring B.V.: R&D Expenditures, 2017 and 2018
    • Figure 54: Sanofi: Revenue Share, by Region, 2018
    • Figure 55: Sanofi: Revenue Share, by Business Segment, 2018
    • Figure 56: Sanofi: Sales Revenue from Synvisc/Synvisc-One, 2015-2018
    • Figure 57: Sanofi: R&D Expenditures, 2015-2018
    • Figure 58: Seikagaku Corp.: Revenue Share, by Region, 2018
    • Figure 59: Seikagaku Corp.: Revenue Share, by Business Segment, 2018
    • Figure 60: Seikagaku Corp.: Sales Revenue from Gel-One, Visco-3, and Supartz, 2015-2018
    • Figure 61: Seikagaku Corp.: R&D Expenditures, 2015-2018
Back to Top